home.social

#safetyprofile — Public Fediverse posts

Live and recent posts from across the Fediverse tagged #safetyprofile, aggregated by home.social.

fetched live
  1. AbbVie Announces European Commission Approval of RINVOQ® (upadacitinib) for the Treatment of Adults and Adolescents with Non-Segmental Vitiligo

    “Given the immune-mediated and unpredictable nature of non-segmental vitiligo, holistic therapeutic management including early diagnosis, appropriate treatment and…
    #Europe #EU #EuropeanCommission #AbbVie #adolescentpatients #RINVOQ #safetyprofile
    europesays.com/europe/105530/

  2. Sanofi Rare Disease Pipeline Progress Puts Recent Share Price Weakness In Focus

    Find winning stocks in any market cycle. Join 7 million investors using Simply Wall St’s investing ideas for…
    #France #FR #Europe #EU #Sanofi #neurologicalsymptoms #raredisease #safetyprofile #type3Gaucherdisease
    europesays.com/france/26627/

  3. Sanofi’s Efdoralprin Alfa Data Add Rare Disease Angle To Growth Story

    Make better investment decisions with Simply Wall St’s easy, visual tools that give you a competitive edge. Sanofi…
    #France #FR #Europe #EU #Sanofi #AAT #investmentdecisions #plasmatherapy #respiratorydisease #safetyprofile
    europesays.com/france/17332/

  4. Implantica announces landmark RefluxStop® study of 602 patients across 22 European centers, with up to 6.75-year follow-up, published in Nature’s Scientific Reports

    VADUZ, Liechtenstein, April 21, 2026 /PRNewswire/ — Implantica AG (publ.), a medtech company at the forefront of intr…
    #Europe #EU #acidreflux #European #FDAapproval #GERDpatients #hiatalhernia #ImplanticaAG #milestonestudy #outcomesstudy #safetyprofile #ScientificReports #SebastianSchoppmann
    europesays.com/europe/18704/